Skip to product information
1 of 1

MULTI SCIENCES

Mouse MCPT-1/mMCP-1 ELISA Kit Plate

Mouse MCPT-1/mMCP-1 ELISA Kit Plate

SKU:EK2176

Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

Mouse MCPT-1/mMCP-1 ELISA Kit Plate

Brand MultiSciences
CatNum 70-EK2176
Product Name Mouse MCPT-1/mMCP-1 ELISA Kit
Customs Name Mouse MCPT-1/mMCP-1 ELISA Kit
Application ELISA
Reactivity Mouse
Assay Type Sandwich ELISA
Suitable Sample Type serum, plasma, cell culture supernates
Format 96-well strip plate
Storage 4℃ (unopened) standard stored at -20℃, others stored at 4℃ (opened)
Shipping Condition 4℃
Sample Volume 100 μl (prediluted)
Sensitivity 44.56 pg/ml
Standard Curve Range 62.50 - 4000 pg/ml
Spike Recovery Range 80 % - 89 %
Mean Spike Recovery 0.84
CV of Intra plate 2.9 % - 3.9 %
CV of Inter plate 1.4 % - 3.5 %
Components 96-well polystyrene microplate coated with a monoclonal antibody against MCPT-1
Mouse MCPT-1 Standard, lyophilized
MCPT-1 Detect Antibody
Standard Diluent
Streptavidin-HRP
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
Washing Buffer (20×)
Plate Covers
Describtion This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of mouse MCPT-1. The Mouse MCPT-1/mMCP-1 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Mast cell protease-1 (MCPT-1), also known as β?chymase, is a member of the Chymase family of chymotrypsin-like serine proteases and is the only chymase expressed by intestinal mucosal mast cells. Its activation is completed by the removal of a two residue N?terminal propeptide by a dipeptidyl peptidase (Cathepsin C). Like human α?Chymase, MCPT-1 is capable of the conversion of angiotensin I to angiotensin II, which plays a key role in the regulation of arterial pressure. MCPT-1 promotes mucosal permeability in intestinal allergic hypersensitivity reactions and plays an important role in host defense against intestinal parasites. Studies have shown that specific chymase inhibitors are able to diminish the development of abdominal aortic aneurysm and reduce the adhesion formation after cardiac surgery in hamsters. Therefore, the development of specific inhibitors of chymase activity has been a pharmacologic strategy to develop therapeutic agents.